Sutton Wealth Advisors’s AngioDynamics ANGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-634
Closed -$8.73K 846
2022
Q4
$8.73K Buy
634
+169
+36% +$2.35K ﹤0.01% 991
2022
Q3
$9.51K Hold
465
﹤0.01% 906
2022
Q2
$9K Buy
465
+5
+1% +$102 ﹤0.01% 930
2022
Q1
$9.91K Sell
460
-4
-0.9% -$91 ﹤0.01% 932
2021
Q4
$12.8K Buy
464
+9
+2% +$248 ﹤0.01% 850
2021
Q3
$11.8K Hold
455
﹤0.01% 851
2021
Q2
$12.3K Hold
455
﹤0.01% 843
2021
Q1
$10.6K Hold
455
﹤0.01% 864
2020
Q4
$6.97K Hold
455
﹤0.01% 906
2020
Q3
$5.49K Hold
455
﹤0.01% 902
2020
Q2
$4.63K Hold
455
﹤0.01% 923
2020
Q1
$4.75K Buy
+455
New +$5.71K ﹤0.01% 828
2019
Q4
Sell
-494
Closed -$9.1K 1168
2019
Q3
$9.1K Hold
494
0.01% 815
2019
Q2
$9.73K Hold
494
0.01% 772
2019
Q1
$11.3K Hold
494
0.01% 761
2018
Q4
$9.94K Hold
494
0.01% 744
2018
Q3
$10.7K Hold
494
0.01% 772
2018
Q2
$11K Hold
494
0.01% 810
2018
Q1
$8.52K Buy
+494
New +$8.24K 0.01% 855

Other funds holding ANGO

Sutton Wealth Advisors's ANGO Position: Q1 2023 in Review

Sutton Wealth Advisors sold out of AngioDynamics (ANGO) in Q1 2023, closing a stake of 634 shares — an estimated $8.73K sold.

Sutton Wealth Advisors first reported a position in ANGO in Q1 2018 and held it in 19 quarters. The position peaked at $12.8K in Q4 2021. 153 funds tracked by Wall St. Rank hold ANGO as of Q1 2023.

  • Sutton Wealth Advisors reported no remaining AngioDynamics position as of Q1 2023 after selling out during the quarter.
  • Sutton Wealth Advisors sold 634 AngioDynamics shares in Q1 2023, an estimated $8.73K.
  • Sutton Wealth Advisors first reported a position in AngioDynamics in Q1 2018 and held it in 19 quarters.
  • Sutton Wealth Advisors's AngioDynamics position peaked at $12.8K in Q4 2021.
  • 153 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2023.

Based on Sutton Wealth Advisors's 13F filing for Q1 2023, filed 7 Nov 2023.